{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:08:49Z","timestamp":1776172129666,"version":"3.50.1"},"reference-count":32,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background: Heart failure (HF) is a complex disease and one of the major causes of morbidity and mortality in the world. Increased B-type natriuretic peptide (BNP) levels have been associated with HF. The NPPB:rs198389 (c.-381T &gt; C) promoter polymorphism has been found to modulate BNP levels. Aim: To investigate possible associations among the NPPB:rs198389 polymorphism, N-terminal pro-BNP (NT-proBNP) concentrations, and phenotypic features in Polish patients with HF. Methods: The study group comprised 250 patients with HF. Genomic DNA was extracted from blood, and genotyping was performed using PCR-RFLP. Results: There were no significant differences in the distributions of NPPB genotypes or alleles between HF females and HF males. Except for body height, there were no significant differences in phenotypic features among HF patients regarding NPPB:rs198389 genotypes. There were also no significant differences in the distributions of either NPPB:rs198389 genotypes or alleles across NT-proBNP concentration terciles. However, age, left-ventricular-mass index, C-reactive-protein levels, serum-creatinine concentrations, and the incidence of myocardial infarction, left ventricular hypertrophy, or reduced ejection fraction (EF) were significantly lower in patients from the lower tercile (LT) than in patients from the middle and\/or upper terciles. EF and the frequency of preserved EF in LT patients were significantly higher than those from other terciles. Conclusions: Our results did not confirm associations between NPPB:rs198389 and NT-proBNP serum concentrations or clinical phenotypes in Polish patients with HF.<\/jats:p>","DOI":"10.3390\/genes17040454","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:23:56Z","timestamp":1776169436000},"page":"454","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association Analyses Between the NPPB:rs198389 Gene Polymorphism, NT-proBNP Serum Concentrations and Phenotypic Features in Patients with Heart Failure"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9288-8689","authenticated-orcid":false,"given":"Anna","family":"Gor\u0105cy-Rosik","sequence":"first","affiliation":[{"name":"Department of Clinical and Molecular Biochemistry, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7377-4566","authenticated-orcid":false,"given":"Jakub","family":"Rosik","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6732-2341","authenticated-orcid":false,"given":"Klaudyna","family":"Lewandowska","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Biochemistry, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Gor\u0105cy","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Biochemistry, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3804-440X","authenticated-orcid":false,"given":"Andrzej","family":"Ciechanowicz","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Biochemistry, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Bohdan, M., Kowalczys, A., Nessler, J., Straburzy\u0144ska-Migaj, E., Grucha\u0142a, M., and Lelonek, M. (2025). Heart Failure in Poland: A 20-Year Epidemiological Perspective. Medicina, 61.","DOI":"10.3390\/medicina61081472"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.1161\/CIR.0000000000001307","article-title":"Risk-Based Primary Prevention of Heart Failure: A Scientific Statement from the American Heart Association","volume":"151","author":"Khan","year":"2025","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"107863","DOI":"10.1016\/j.pharmthera.2021.107863","article-title":"The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications","volume":"227","author":"Kuwahara","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/bmjebm-2019-111208","article-title":"Natriuretic peptide-guided treatment for heart failure: A systematic review and meta-analysis","volume":"25","author":"McLellan","year":"2020","journal-title":"BMJ Evid.-Based Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrcardio.2014.64","article-title":"Natriuretic peptides in cardiometabolic regulation and disease","volume":"11","author":"Zois","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_9","first-page":"19162","article-title":"Correlation between rs198388 and rs198389 polymorphisms in brain natriuretic peptide (NPPB) gene and susceptibility to congenital heart diseases in a Chinese population","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gor\u0105cy-Rosik, A., Fic, M., Rosik, J., Lewandowska, K., Safranow, K., Ciechanowicz, A., and Gor\u0105cy, I. (2025). The Genetic Polymorphisms of NPPA:rs5065 and NPPB:rs198389 and Intermediate Phenotypes of Heart Failure in Polish Patients. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26104567"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e005257","DOI":"10.1161\/JAHA.116.005257","article-title":"An NPPB Promoter Polymorphism Associated with Elevated N-Terminal pro-B-Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality","volume":"6","author":"Seidelmann","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jacbts.2021.05.001","article-title":"STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart Failure","volume":"6","author":"Cannone","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_13","first-page":"1463","article-title":"Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: A Mendelian randomization study in the FINRISK cohort","volume":"22","author":"Geelhoed","year":"2020","journal-title":"EP Eur."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/eurjhf\/hft007","article-title":"Common genetic variants of the natriuretic peptide gene locus are not associated with heart failure risk in participants in the EPIC-Norfolk study","volume":"15","author":"Pfister","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/sim.973","article-title":"Sample size requirements for matched case-control studies of gene\u2013environment interaction","volume":"21","author":"Gauderman","year":"2002","journal-title":"Stat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.5603\/KP.a2014.0215","article-title":"Association of genetic variation in the natriuretic peptide system and left ventricular mass and blood pressure in newborns","volume":"73","author":"Dawid","year":"2015","journal-title":"Kardiol. Pol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2217\/bmm-2021-0055","article-title":"Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study)","volume":"15","author":"Puleo","year":"2021","journal-title":"Biomark. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"c93","DOI":"10.1159\/000157622","article-title":"Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients","volume":"110","author":"Choi","year":"2008","journal-title":"Nephron Clin. Pract."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"H545","DOI":"10.1152\/ajpheart.00321.2023","article-title":"Sex-based differences in metabolic protection by the ANP genetic variant rs5068 in the general population","volume":"325","author":"Ichiki","year":"2023","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/hmg\/ddw012","article-title":"Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome","volume":"25","author":"Johansson","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/hmg\/ddm084","article-title":"Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations","volume":"16","author":"Meirhaeghe","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/CIRCGENETICS.114.000900","article-title":"Genome-wide association analysis of plasma B-type natriuretic peptide in blacks: The Jackson Heart Study","volume":"8","author":"Musani","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.yjmcc.2011.01.010","article-title":"Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes","volume":"50","author":"Ellis","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.14715\/cmb\/2023.69.13.28","article-title":"Relationship between lipid profile and B-type natriuretic peptide T-381C (rs198389) gene polymorphism in patients with stable coronary artery disease","volume":"69","year":"2023","journal-title":"Cell. Mol. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14740\/cr523w","article-title":"Sex Differences of the Natriuretic Peptide Polymorphism Associated with Angiographic Coronary Atherosclerosis","volume":"8","author":"Li","year":"2017","journal-title":"Cardiol. Res."},{"key":"ref_26","first-page":"7148","article-title":"Association of natriuretic peptide polymorphisms with left ventricular dysfunction in southern Han Chinese coronary artery disease patients","volume":"7","author":"Wu","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/hmg\/ddp169","article-title":"The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: An updated meta-analysis in 49 279 subjects","volume":"18","author":"Choquet","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Pfister, R., Sharp, S., Luben, R., Welsh, P., Barroso, I., Salomaa, V., Meirhaeghe, A., Khaw, K.T., Sattar, N., and Langenberg, C. (2011). Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: Evidence of causal association from population studies. PLoS Med., 8.","DOI":"10.1371\/journal.pmed.1001112"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1373\/clinchem.2012.194167","article-title":"Prospective evaluation of B-type natriuretic peptide concentrations and the risk of type 2 diabetes in women","volume":"59","author":"Everett","year":"2013","journal-title":"Clin. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.gene.2015.04.073","article-title":"Examination of the brain natriuretic peptide rs198389 single-nucleotide polymorphism on type 2 diabetes mellitus and related phenotypes in an Algerian population","volume":"567","author":"Meroufel","year":"2015","journal-title":"Gene"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.20452\/pamw.658","article-title":"SNP rs198389 (T-381C) polymorphism in the B-type natriuretic peptide gene promoter in patients with atherosclerotic renovascular hypertension","volume":"119","author":"Poreba","year":"2009","journal-title":"Pol. Arch. Med. Wewn."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00125-003-1047-2","article-title":"Association between polymorphisms of the atrial natriuretic peptide gene and proteinuria: A population-based study","volume":"46","author":"Nannipieri","year":"2003","journal-title":"Diabetologia"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/4\/454\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:31:21Z","timestamp":1776169881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/4\/454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["genes17040454"],"URL":"https:\/\/doi.org\/10.3390\/genes17040454","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]}}}